Global Cardiometabolic Policy Leader

Merck

Rahway (NJ)

Ibrido

USD 191.000 - 300.000

Tempo pieno

5 giorni fa
Candidati tra i primi

Una candidatura completa in un minuto

Curriculum e lettera di presentazione personalizzati, pronti da inviare.

Supera i filtri ATS

Vantaggi offerti da questo lavoro

Medical benefits
Dental benefits
Vision benefits
401(k) retirement
Paid holidays
Vacation
Sick days

Descrizione del lavoro

Merck is seeking a Director to lead global public policy efforts for cardiometabolic diseases, driving strategies across global, regional, and country teams. The role supports cardiovascular and metabolic pipelines with cross-functional collaboration.

You will analyze policy issues, shape policy strategy, and advocate for priorities aligned with Merck's strategic business goals, including public-private partnerships and stakeholder engagement.

Competenze

  • BS/BA required; Master’s preferred in health policy.
  • 10+ years addressing public policy issues in global space.
  • Strong knowledge of noncommunicable diseases and stakeholder engagement.

Mansioni

  • Develop and implement global public policy strategies.
  • Collaborate with global franchise teams and regional policy groups.
  • Advise on policy solutions to support cardiometabolic pipelines.

Conoscenze

Policy development
Global leadership
Stakeholder analysis
Regulatory development
Noncommunicable diseases

Formazione

BS/BA
Master’s degree

Descrizione del lavoro

Merck is seeking a Director to lead global public policy efforts for cardiometabolic diseases, driving strategies across global, regional, and country teams. The role supports cardiovascular and metabolic pipelines with cross-functional collaboration.

You will analyze policy issues, shape policy strategy, and advocate for priorities aligned with Merck's strategic business goals, including public-private partnerships and stakeholder engagement.

Ottieni la revisione del curriculum gratis e riservata.

o trascina qui il file.

Similar jobs

Offerte di lavoro simili che vale la pena confrontare

Global Policy Lead for Cardiometabolic Health
Global Policy Lead for Cardiometabolic Health

Merck & Co. • North Wales

Ibrido
USD 191.000 - 300.000
Medical benefits
Dental benefits
Vision benefits
+2
Director, Global Regulatory Strategy — Cardiometabolic
Director, Global Regulatory Strategy — Cardiometabolic

Regulatory Toolkit • Stati Uniti

Remoto
USD 196.000 - 265.000
Retirement plan
Medical benefits
Annual bonus
+1
Policy Solutions Director, Global Health
Policy Solutions Director, Global Health

Merck • Rahway (NJ)

In loco
USD 191.000 - 300.000
Medical benefits
Retirement benefits (401(k))
Paid holidays & vacation
Global Policy Solutions Director
Global Policy Solutions Director

Merck & Co. • Washington

Ibrido
USD 191.000 - 300.000
Principal Scientist, Clinical Research – Cardiometabolic
Principal Scientist, Clinical Research – Cardiometabolic

Merck • New Jersey

In loco
USD 180.000 - 260.000
Global Regulatory Director — Cardiometabolic Disorders
Global Regulatory Director — Cardiometabolic Disorders

BioSpace • Washington

In loco
USD 190.000 - 300.000
Retirement and Savings Plan
Stock-based long-term incentives
Award-winning time-off plans
+1
Senior Director, Global Regulatory — Cardiometabolic
Senior Director, Global Regulatory — Cardiometabolic

Amgen SA • Stati Uniti

Remoto
USD 180.000 - 240.000
Total Rewards Plan
Stock-based incentives
Flexible work models
+1
Global Regulatory Director: Obesity & Metabolic Health
Global Regulatory Director: Obesity & Metabolic Health

Amgen Inc. • Stati Uniti

Remoto
USD 196.000 - 265.000
Total Rewards Plan
Stock-based long-term incentives
Flexible work models
Global Policy Solutions Director
Global Policy Solutions Director

Merck & Co. • Rahway (NJ)

Ibrido
USD 191.000 - 300.000
Hybrid work
Competitive benefits
Global Regulatory Lead for Obesity & Metabolic Disorders
Global Regulatory Lead for Obesity & Metabolic Disorders

Amgen Inc. • Thousand Oaks (CA)

Ibrido
USD 196.000 - 265.000
Retirement and Savings Plan
Medical, Dental, Vision benefits
Stock-based long-term incentives
+1